Form 990 for tax year 2023
Filed by ADVANCED REGENERATIVE MANUFACTURING INSTITUTE INC.
Totals
- Total revenue
- $26,819,069
- Total expenses
- $26,309,774
- Contributions and grants received
- $24,486,867
- Grants paid
- $11,333,391
- Program service revenue
- $2,229,394
- Investment income
- $102,808
- Other revenue
- $0
- Total assets, end of year
- $29,045,430
- Total liabilities, end of year
- $11,371,178
- Net assets or fund balances, end of year
- $17,674,252
- Program services expenses (Part IX)
- not reported
- Management and general expenses
- not reported
- Fundraising expenses
- not reported
- Program service expenses (Part III)
- not reported
Line items
Every line the filer filed in Parts VIII, IX and X, as filed and in filed order. Blank columns are left out, and the lines are not forced to add up to the totals above.
Revenue
Part VIII, the statement of revenue.
-
1e · Government grants (contributions)
$23,981,837
-
1f · All other contributions, gifts and grants
$505,030
-
2a · Program service revenue: Membership Dues
total $1,076,179 · related or exempt $1,076,179
-
2b · Program service revenue: Management Fee Revenue
total $712,874 · related or exempt $712,874
-
2c · Program service revenue: Other Program Revenue
total $440,341 · related or exempt $440,341
-
3 · Investment income
total $102,808 · excluded $102,808
Functional expenses
Part IX, the statement of functional expenses.
-
1 · Grants to domestic organizations and governments
total $10,702,911
-
3 · Grants to foreign organizations and individuals
total $630,480
-
5 · Compensation of officers, directors and key employees
total $285,458
-
7 · Other salaries and wages
total $5,676,792
-
8 · Pension plan contributions
total $131,731
-
9 · Other employee benefits
total $489,210
-
10 · Payroll taxes
total $443,025
-
11b · Fees: legal
total $55,638
-
11c · Fees: accounting
total $45,000
-
11g · Fees: other
total $1,288,760
-
12 · Advertising and promotion
total $29,716
-
13 · Office expenses
total $366,339
-
14 · Information technology
total $433,756
-
16 · Occupancy
total $1,037,269
-
17 · Travel
total $176,395
-
19 · Conferences, conventions and meetings
total $666,717
-
22 · Depreciation, depletion and amortization
total $2,141,641
-
23 · Insurance
total $35,646
-
24a · Other expenses: Lab Materials and Suppl
total $1,673,290
Balance sheet
Part X, book values.
-
1 · Cash, non-interest-bearing
beginning of year $224,206 · end of year $140,238
-
2 · Savings and temporary cash investments
beginning of year $9,697,118 · end of year $8,126,955
-
4 · Accounts receivable
beginning of year $4,452,276 · end of year $6,802,994
-
9 · Prepaid expenses and deferred charges
beginning of year $398,735 · end of year $597,427
-
10a · Land, buildings and equipment: cost or other basis
$16,583,628
-
10b · Land, buildings and equipment: accumulated depreciation
$5,657,543
-
10c · Land, buildings and equipment, net
beginning of year $10,652,869 · end of year $10,926,085
-
14 · Intangible assets
beginning of year $119,415 · end of year $76,975
-
15 · Other assets
beginning of year $3,105,042 · end of year $2,374,756
-
17 · Accounts payable and accrued expenses
beginning of year $6,919,240 · end of year $5,334,402
-
19 · Deferred revenue
beginning of year $1,460,422 · end of year $2,204,573
-
22 · Loans and payables to officers and key people
end of year $1,457,447
-
25 · Other liabilities
beginning of year $3,105,042 · end of year $2,374,756
-
27 · Net assets without donor restrictions
beginning of year $17,164,957 · end of year $17,674,252
Mission and programs · 2023
Mission
ARMI's mission is to support, develop, advance and promote the United States bioeconomy.
-
ARMI and its BioFabUSA Institute accomplishes its mission through key activities, such as the following:- Collaborates with community, local, State, and Federal stakeholders to advance the U.S bioeconomy and fuel inclusive economic growth, including by creating pathways and access to jobs in the biofabrication industry. - Provides wrap-around commercialization services for tissue engineering and enabling technology companies. These efforts de-risk and accelerate translation of impactful technologies to market. - Funds technical projects that address many of the common manufacturing challenges faced by companies in the field of tissue engineering. This will allow tissue engineering and enabling technology companies to focus their time and resources on product-specific challenges, moving the entire industry forward more quickly and efficiently. - Funds education and workforce development (EWD) projects that address the industry need for trained employees with a broad base of biomanufacturing skills and specific expertise. This pressing need can otherwise constrain the growth of tissue engineering and enabling technology companies. - In coordination with organizations in the field of regenerative manufacturing, develops roadmaps of technical and EWD needs for the field. These roadmaps guide the work of organizations in the field of regenerative manufacturing and guide the selection of projects. - Hosts, sponsors, and participates in conferences and workshops that convene organizations that support regenerative manufacturing. These events allow for shared learning related to technical, regulatory, workforce, and financial challenges and solutions. - Shares information about best practices and innovations in the field via various fora and online resources.NextFab accomplishes is mission through key activities, such as the following: - Develop commercial advisory and consulting programs designed to accelerate adoption of advanced technologies. - Provide shared facilities to accelerate advanced technologies. - Performs projects of interest to U.S. Department of Health and Human Services.
As filed on the 2023 return. The filer continues this part on Schedule O, which is not shown here.
Listed in Part VII
-
Dean Kamen
Executive Director
- Total calculated
- $0
- Hours/week
- 5
-
Martine Rothblatt
Board Member
- Total calculated
- $0
- Hours/week
- 1
-
John Abele
Board Member
- Total calculated
- $0
- Hours/week
- 1
-
Jim Weinstein
Board Member
- Total calculated
- $0
- Hours/week
- 1
-
Blake Moret
Board Member
- Total calculated
- $0
- Hours/week
- 1
-
Maureen Toohey
Deputy Executive Director
- Total calculated
- $0
- Hours/week
- 15
-
James Scott
Chief Administrative Officer
- Total calculated
- $0
- Hours/week
- 15
-
Brendan Duffy
Treasurer
- Total calculated
- $0
- Hours/week
- 1
-
Jennifer MacDonald
Chief Operating Officer
- Total calculated
- $285,458
- From this org
- $257,584
- From related orgs
- $0
- Other
- $27,874
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $232,584
- Bonus
- $25,000
- Other
- $0
- Deferred
- $3,269
- Nontaxable benefits
- $24,605
- Filer's total
- $285,458
-
Julie Lenzer
Chief Innovation Officer
- Total calculated
- $221,038
- From this org
- $196,065
- From related orgs
- $0
- Other
- $24,973
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $196,065
- Bonus
- $0
- Other
- $0
- Deferred
- $8,009
- Nontaxable benefits
- $16,964
- Filer's total
- $221,038
-
Richard McFarland
Chief Regulatory Officer
- Total calculated
- $222,959
- From this org
- $194,203
- From related orgs
- $0
- Other
- $28,756
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $194,203
- Bonus
- $0
- Other
- $0
- Deferred
- $8,005
- Nontaxable benefits
- $20,751
- Filer's total
- $222,959
-
Edward Gordon
BioFab Chief Operating Officer
- Total calculated
- $234,883
- From this org
- $191,771
- From related orgs
- $0
- Other
- $43,112
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $191,771
- Bonus
- $0
- Other
- $0
- Deferred
- $8,010
- Nontaxable benefits
- $35,102
- Filer's total
- $234,883
-
Karla Talanian
Past Chief Workforce Development Officer
- Total calculated
- $174,325
- From this org
- $170,291
- From related orgs
- $0
- Other
- $4,034
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $170,291
- Bonus
- $0
- Other
- $0
- Deferred
- $2,908
- Nontaxable benefits
- $1,126
- Filer's total
- $174,325
-
Michael Orrico
BioFab Startup Lab Manager
- Total calculated
- $185,005
- From this org
- $166,835
- From related orgs
- $0
- Other
- $18,170
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $166,835
- Bonus
- $0
- Other
- $0
- Deferred
- $2,962
- Nontaxable benefits
- $15,208
- Filer's total
- $185,005
Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those. A Schedule J breakdown is as filed: base pay, bonus, other, deferred compensation and nontaxable benefits from this organization, with any from related organizations beside each, and the filer's own total. It is shown with the Part VII listing of the same name on the same return. The form gives no key between the two, so that pairing is ours, and is marked matched by us.
Schedule J
Answered yes
None.
Answered no
- 4a · Severance or change-of-control payment
- 4b · Supplemental nonqualified retirement plan
- 4c · Equity-based compensation arrangement
The filer's explanations (Part III)
- Part I, Line 7
- During the calendar year 2023, a one time starting bonus of $25,000 was paid to Jennifer MacDonald and was approved by the Deputy Executive Director.
Part I's answers as filed. A line not listed was left unanswered; on lines 1a and 3 that means the box was not checked.
Grants on this return
-
BETA Technologies Inc
$4,795,913
See Part IV
-
$1,225,324
See Part IV
-
DEKA Integrated Solutions Corp
$450,000
See Part IV
-
$415,319
See Part IV
-
$398,058
See Part IV
-
Sciperio Inc
$300,000
See Part IV
-
University of California Davis
$291,715
See Part IV
-
$255,227
See Part IV
-
See Part IV
-
$185,296
See Part IV
The 10 largest by cash amount. The API serves every itemized grant.
Related organizations on this return
Schedule R Part II: tax-exempt organizations related to the filer by control. It does not record shared board members or money.
-
ARMI Research Collaborative Inc
501(c)(3) · See Part VII · NH · controlled entity
Directly controlled by Advanced Regenerative Manufacturing Institute Inc
Taxable family on this return
Schedule R Parts I, III and IV, as filed. These record ownership and control, not shared board members or money moved.
Related corporations and trusts
Part IV: related organizations taxable as a corporation or trust.
-
ARMI Bioindustries Corp
C · Biotech Manufacturing and Development Services · NH · 100% owned · share of income $778,717 · share of assets $250,486 · controlled entity
Directly controlled by Advanced Regenerative Manufacturing Institute Inc
Provenance
- Return type
- form_990
- Tax year
- 2023
- Filed
- 15 November 2024
- IRS schema version
- 2023v5.1
- Source object
- 202423209349318732
Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.
The source document this was parsed from is served over the API, which is where bulk and document access live.